Home Français Menu


shopping cart icon

Job Board > Postdoctoral Fellow - RSV - VIDO

Postdoctoral Fellow - RSV - VIDO

Province: Saskatoon, Saskatchewan
Position: Postdoctoral Fellow - RSV
Deadline: December 31, 2021

Job Description / Duties

Dr. Sylvia van den Hurk is seeking an outstanding Postdoctoral Fellow focusing on respiratory syncytial virus and parainfluenza virus to join her research team. Respiratory syncytial virus and parainfluenza virus are major causes of severe respiratory infections in young infants and elderly. Since these viruses are pneumotropic, induction of protective local immunity by vaccination is desirable. We have developed vaccine candidates against RSV and PIV-3 that induce long-term mucosal immunity in several animal models. The successful candidate will work on establishing the correlates of protection induced by these vaccines including metabolic effects, as well as the mechanism of action using in vitro and in vivo model systems.

Qualifications / Required Skills

The successful candidate will have recently completed a PhD (in the past three years) in Microbiology or Immunology, or another related discipline. The ideal candidate should have a strong background in virology, immunology, and/or vaccinology. Candidates with experience in primary immune cell culture and/or fluorescence-activated cell sorting are preferred. Must be a team player with excellent oral and written communication skills. Effective organizational, and time management skills are required.

Additional Information

Status: 2-year term, with the possibility of extension
Employment Group: Post-Doctoral Fellows – PSAC
Full Time Equivalent (FTE): 1.0
Salary Information: The starting salary will follow the university standard for a post-doctoral researcher and will be commensurate with experience.

The successful applicant will be required to provide the following current verification(s) where 'Yes' is indicated below. Further information is available at: https://careers.usask.ca/tips-for-applying.php#Howtoapplyforaposition

Facility Access Screening including Criminal Record Check: Yes
Driver's License and Abstract Check: Not Applicable
Education/Credential Verification: Yes
Vulnerable Sector Check: Not Applicable

Interested candidates are asked to submit their application in one single application document (pdf file) 1) statement of research interest, 2) a complete curriculum vitae (CV), and 3) contact information for three references.

Review of applications will begin immediately; however, applications will be accepted and evaluated until the position is filled. We thank all applicants for their interest; only those candidates selected for an interview will be contacted.

For more information visit: vido.org

Note: The University believes equity, diversity, and inclusion strengthen the community and enhance excellence, innovation and creativity. We are dedicated to recruiting individuals who will enrich our work and learning environments. All qualified candidates are encouraged to apply; however, in accordance with Canadian immigration requirements, Canadian citizens and permanent residents will be given priority. We are committed to providing accommodations to those with a disability or medical necessity. If you require an accommodation in order to participate in the recruitment process, please notify us and we will work together on the accommodation request. The University of Saskatchewan’s main campus is situated on Treaty 6 Territory and the Homeland of the Métis. We pay our respects to the First Nations and Métis ancestors of this place and reaffirm our relationship with one another. Together, we are uplifting Indigenization to a place of prominence at the University of Saskatchewan.

Contact Information

Please apply online: https://www.vido.org/careers/current-opportunities/

Employer Profile

The Vaccine and Infectious Disease Organization (VIDO) is Canada’s Centre for Pandemic Research. Located at the University of Saskatchewan in Saskatoon, Canada, VIDO is a leader in human and animal infectious disease research and vaccine development. For over 45 years we have developed solutions to emerging diseases including eight commercially available vaccines—six of which were world’s firsts, with four more in regulatory development.

As a National Centre, we are home to one of the largest and most advanced level 3 containment facilities capable of housing both small and large animals including rodents, poultry, pigs, cattle, and bison. We are currently expanding our specialized infrastructure to include a vaccine GMP manufacturing facility, a new multi-species level 2 animal facility, and upgraded capacity to include level 4 containment. Our vision includes the capacity to study any emerging disease in any animal model embracing a One Health approach to prevent emerging and re-emerging infectious disease of importance in human and veterinary health.